Protective Effect of Epigallocatechin-3-Gallate (EGCG) in Diseases with Uncontrolled Immune Activation: Could Such a Scenario Be Helpful to Counteract COVID-19?

Some coronavirus disease 2019 (COVID-19) patients develop acute pneumonia which can result in a cytokine storm syndrome in response to Severe Acute Respiratory Syndrome coronavirus 2 (SARS-CoV-2) infection. The most effective anti-inflammatory drugs employed so far in severe COVID-19 belong to the c...

Descripción completa

Detalles Bibliográficos
Autores principales: Menegazzi, Marta, Campagnari, Rachele, Bertoldi, Mariarita, Crupi, Rosalia, Di Paola, Rosanna, Cuzzocrea, Salvatore
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7404268/
https://www.ncbi.nlm.nih.gov/pubmed/32708322
http://dx.doi.org/10.3390/ijms21145171

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7404268/
https://www.ncbi.nlm.nih.gov/pubmed/32708322
http://dx.doi.org/10.3390/ijms21145171

Ejemplares similares